Funder
Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Ihne S, Morbach C, Obici L, Palladini G, Stork S (2019) Amyloidosis in heart failure. Curr Heart Fail Rep 16:285–303
2. Ihne S, Morbach C, Sommer C, Geier A, Knop S, Stork S (2020) Amyloidosis-the diagnosis and treatment of an underdiagnosed disease. Dtsch Arztebl Int 117:159–166
3. Treglia G, Martinello C, Dondi F et al (2023) Prevalence of incidental findings suspicious for transthyretin cardiac amyloidosis among patients undergoing bone scintigraphy: a systematic review and a meta-analysis. J Clin Med 12:5698
4. Antonopoulos AS, Panagiotopoulos I, Kouroutzoglou A et al (2022) Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta-analysis. Eur J Heart Fail 24:1677–1696
5. Gillmore JD, Maurer MS, Falk RH et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133:2404–2412